Published in J Clin Microbiol on October 01, 1998
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol (2001) 1.37
Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut (2002) 1.09
Transport and storage of fresh and frozen gastric biopsy specimens for optimal recovery of Helicobacter pylori. J Clin Microbiol (1999) 0.94
Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis. J Clin Pathol (2007) 0.84
Liquid culture medium for the rapid cultivation of Helicobacter pylori from biopsy specimens. Eur J Clin Microbiol Infect Dis (2008) 0.79
Evaluation of a serum-free transport medium supplemented with cyanobacterial extract, for the optimal survival of Helicobacter pylori from biopsy samples and strains. Eur J Clin Microbiol Infect Dis (2011) 0.77
Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences. World J Gastroenterol (2015) 0.77
New transport medium for cultural recovery of Helicobacter pylori. J Clin Microbiol (2014) 0.76
Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol (1985) 6.78
Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. J Clin Microbiol (1985) 4.93
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet (1994) 4.07
Indicator medium for isolation of Campylobacter pylori. J Clin Microbiol (1987) 3.44
Effect of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsy specimens. J Clin Pathol (1993) 1.66
Optimal survival of Helicobacter pylori under various transport conditions. J Clin Microbiol (1992) 1.44
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter (1996) 1.27
Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis (1995) 1.25
Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time. Antimicrob Agents Chemother (1997) 1.21
Transport conditions and number of biopsies necessary for culture of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1991) 1.19
Determination of the optimal transport system for Helicobacter pylori cultures. J Med Microbiol (1993) 1.18
Enhanced cultivation of Helicobacter pylori in liquid media. J Clin Pathol (1993) 1.15
In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. J Antimicrob Chemother (1997) 1.04
Effect of specimen collection techniques, transport media, and incubation of cultures on the detection rate of Helicobacter pylori. Eur J Clin Microbiol Infect Dis (1996) 0.90
Helicobacter pylori--molecular genetics and diagnostic typing. Br Med Bull (1998) 0.86
Recovery of Helicobacter pylori from gastric biopsy specimens is not dependent on the transport medium used. J Clin Microbiol (1995) 0.85
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet (1998) 12.89
Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet (1993) 8.54
The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med (2000) 5.73
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med (1995) 5.15
Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol (2005) 5.13
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med (2000) 4.33
Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol (2001) 4.08
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet (1994) 4.07
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet (1997) 3.67
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Laparoscopic repair of perforated peptic ulcer. Br J Surg (1992) 3.35
The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J Mol Biol (1999) 3.25
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proc Natl Acad Sci U S A (1996) 3.25
Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med (2000) 3.12
Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med (1999) 3.07
Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med (2001) 3.02
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology (2000) 2.99
Peptic-ulcer disease. Lancet (2002) 2.92
Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology (2000) 2.83
Laparoscopic versus open appendicectomy: prospective randomised trial. Lancet (1993) 2.83
Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Biol (2001) 2.83
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol (1997) 2.78
Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol (1998) 2.73
Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (1998) 2.73
Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol (2001) 2.57
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet (2002) 2.52
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc (2007) 2.50
Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ (1997) 2.42
Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc (1995) 2.39
Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol (1999) 2.37
Through-the-scope balloon dilation for pyloric stenosis: long-term results. Gastrointest Endosc (1996) 2.36
Obturator hernia revisited: a review of 12 cases in 7 years. J R Coll Surg Edinb (1997) 2.35
Small-bowel perforations related to endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II gastrectomy. Endoscopy (1999) 2.24
A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase. Virology (2001) 2.21
Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg (1996) 2.20
De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 2.19
A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg (1994) 2.12
Gastric adenocarcinoma with ciliated tumor cells. Hum Pathol (1993) 2.08
Retracted New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. Proc Natl Acad Sci U S A (1998) 2.05
The use of a detachable mini-loop for the treatment of esophageal varices. Gastrointest Endosc (1998) 2.04
A randomized study comparing laparoscopic versus open repair of perforated peptic ulcer using suture or sutureless technique. Ann Surg (1996) 2.00
Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage. Am J Clin Pathol (1992) 1.98
Conventional versus laparoscopic surgery for acute appendicitis. Br J Surg (1993) 1.93
Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology (1997) 1.90
The rubble-pile asteroid Itokawa as observed by Hayabusa. Science (2006) 1.87
Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother (2003) 1.87
Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol (1997) 1.82
Streptococcus suis infection in Hong Kong. QJM (1995) 1.74
Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev (2009) 1.71
Subcutaneous emphysema, pneumomediastinum and pneumothorax complicating laparoscopic vagotomy. Report of two cases. Anaesthesia (1993) 1.70
Omitting side-holes in biliary stents does not improve drainage of the obstructed biliary system: a prospective randomized trial. Gastrointest Endosc (1994) 1.67
Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun (1993) 1.66
Evaluation of a novel serotyping system for hepatitis C virus: strong correlation with standard genotyping methodologies. J Clin Microbiol (1995) 1.65
A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology (1996) 1.65
Effect of carbon dioxide pneumoperitoneum on bacteraemia and endotoxaemia in an animal model of peritonitis. Br J Surg (1995) 1.64
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J Virol (2000) 1.63
The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol (1997) 1.63
High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs. Br J Surg (1996) 1.62
Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem (2000) 1.62
Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen. Infect Immun (1992) 1.61
An application of a simple method for the preparation of bacterial DNA. Biotechniques (1992) 1.59
The role of bacteria in the blockage of biliary stents. Gastrointest Endosc (1988) 1.58
EUS-guided injection of cyanoacrylate for bleeding gastric varices. Gastrointest Endosc (2000) 1.57
Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet (1994) 1.55
Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol (1999) 1.53
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis (2000) 1.52
Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years. Dig Dis Sci (1995) 1.51
Comparison of two-dimensional vs three-dimensional camera systems in laparoscopic surgery. Surg Endosc (1997) 1.50
A rapid high-performance liquid chromatographic assay for cefepime, cefpirome and meropenem. J Antimicrob Chemother (1998) 1.50
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J Virol (2001) 1.50
Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol (2000) 1.50
Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol (1997) 1.49
False-negative biopsy urease test in bleeding ulcers caused by the buffering effects of blood. Am J Gastroenterol (1998) 1.48